Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HER2 inhibition: from discovery to clinical practice.

× No keyword cloud information.

11 in total

1. Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic.

Authors: Sashikanth Banappagari; Miriam Corti; Seth Pincus; Seetharama Satyanarayanajois
Journal: J Biomol Struct Dyn Date: 2012-06-26

Review 2. Beyond RAS and BRAF: a target rich disease that is ripe for picking.

Authors: Tyler Friedrich; Stephen Leong; Christopher H Lieu
Journal: J Gastrointest Oncol Date: 2016-10

3. Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast Cancer.

Authors: Shanthi Kanthala; Sashikanth Banappagari; Ameya Gokhale; Yong-Yu Liu; Gu Xin; Yunfeng Zhao; Seetharama Jois
Journal: Chem Biol Drug Des Date: 2014-11-06 Impact factor: 2.817

Review 4. Environmentally responsive peptides as anticancer drug carriers.

Authors: Suhaas Aluri; Siti M Janib; J Andrew Mackay
Journal: Adv Drug Deliv Rev Date: 2009-07-20 Impact factor: 15.470

5. Design, synthesis and characterization of peptidomimetic conjugate of BODIPY targeting HER2 protein extracellular domain.

Authors: Sashikanth Banappagari; Alecia McCall; Krystal Fontenot; M Graca H Vicente; Amit Gujar; Seetharama Satyanarayanajois
Journal: Eur J Med Chem Date: 2013-04-28 Impact factor: 6.514

Review 9. First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?

Authors: Alessandra Fabi; Paola Malaguti; Sabrina Vari; Francesco Cognetti
Journal: J Exp Clin Cancer Res Date: 2016-06-30

Review 10. The Evolution of Cancer Immunotherapy.

Authors: Meshaal Khan; Ajay V Maker; Shikha Jain
Journal: Vaccines (Basel) Date: 2021-06-08

HER2 inhibition: from discovery to clinical practice.